UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 395

Sortiert nach

Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant

Frontiers in oncology, 2020-09, Vol.10, p.573822-573822

2020

Volltextzugriff (PDF)

Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant

Cell transplantation, 2023-01, Vol.32, p.9636897231158155-9636897231158155

2023

Volltextzugriff (PDF)

Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk

Frontiers in oncology, 2021-07, Vol.11, p.706087-706087

2021

Volltextzugriff (PDF)

Three-dimensional prediction of nose morphology in Chinese young adults: a pilot study combining cone-beam computed tomography and 3dMD photogrammetry system

International journal of legal medicine, 2020-09, Vol.134 (5), p.1803-1816

2020

Volltextzugriff (PDF)

The expression and significance of efferocytosis and immune checkpoint related molecules in pancancer samples and the correlation of their expression with anticancer drug sensitivity

Frontiers in pharmacology, 2022-08, Vol.13, p.977025-977025

2022

Volltextzugriff (PDF)

Lip morphology estimation models based on three-dimensional images in a modern adult population from China

International journal of legal medicine, 2021-09, Vol.135 (5), p.1887-1901

2021

Volltextzugriff (PDF)

Three-dimensional superimposition of digital models for individual identification

Forensic science international, 2021-01, Vol.318, p.110597-110597, Article 110597

2021

Volltextzugriff (PDF)

Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors

Frontiers in immunology, 2023-05, Vol.14, p.1161538-1161538

2023

Volltextzugriff (PDF)

Efficacy and side effects of anti‐CD19 CAR T‐cell therapy in patients with relapsed/refractory gastrointestinal lymphoma

Cancer medicine (Malden, MA), 2024-02, Vol.13 (4), p.e7064-n/a

2024

Volltextzugriff (PDF)

Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy

Pharmaceutics, 2023-06, Vol.15 (7), p.1827

2023

Volltextzugriff (PDF)

Trillium tschonoskii maxim extract attenuates abnormal Tau phosphorylation

Neural regeneration research, 2018-05, Vol.13 (5), p.915-922

2018

Volltextzugriff (PDF)

Abstract 1499: Targeting Ras mutation with TCR therapy

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1499-1499

2021

Volltextzugriff (PDF)

Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia

British journal of haematology, 2020-10, Vol.191 (2), p.212-222

2020

Volltextzugriff (PDF)

Three-dimensional Structure Variation of PM 2.5 During Cold Front Advance in Eastern China

Huanjing kexue, 2022-01, Vol.43 (1), p.85

2022

Volltextzugriff (PDF)

Luteolin attenuates the pathogenesis of Staphylococcus aureus by interfering with the agr system

Microbial pathogenesis, 2022-04, Vol.165, p.105496-105496, Article 105496

2022

Volltextzugriff (PDF)

Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL

Annals of hematology, 2023-07, Vol.102 (7), p.1789-1799

2023

Volltextzugriff (PDF)

Anti-CD19-CAR T-Cell from Patients Relapsed after Allo-HSCT with a Low Level of Donor Chimerism Restored to Complete Donor Chimerism: Successful Cases and Analysis

Blood, 2019-11, Vol.134 (Supplement_1), p.5628-5628

2019

Volltextzugriff (PDF)

Humanized anti‐CD19 chimeric antigen receptor‐T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection

Hematological oncology, 2021-02, Vol.39 (1), p.75-86

2021

Volltextzugriff (PDF)

A Refractory B-ALL Patient Relapsed with Leukemia Cells Expressing CD19 and Anti-CD19 CAR Gene 14 Days after CR from Anti-CD19 CAR T-Cell Therapy

Blood, 2019-11, Vol.134 (Supplement_1), p.5124-5124

2019

Volltextzugriff (PDF)

Humanized CD19 CAR-T Cell Combined with Multiple Combination Treatments in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Blood, 2019-11, Vol.134 (Supplement_1), p.5346-5346

2019

Volltextzugriff (PDF)

Efficacy and safety of humanized CD19 CAR‑T as a salvage therapy for recurrent CNSL of B‑ALL following murine CD19 CAR‑T cell therapy

Oncology letters, 2021-11, Vol.22 (5), p.1, Article 788

2021

Volltextzugriff (PDF)

Targeting KRAS G12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors

Frontiers in immunology, 2023, Vol.14, p.1161538

2023

Volltextzugriff (PDF)

Propagating Both Trust and Distrust with Target Differentiation for Combating Link-Based Web Spam

ACM transactions on the web, 2014-06, Vol.8 (3), p.1-33

2014

Volltextzugriff (PDF)

Genetic Structure and Diversity of Parental Cultivars Involved in China Mainland Sugarcane Breeding Programs as Inferred from DNA Microsatellites

Journal of Integrative Agriculture, 2012-11, Vol.11 (11), p.1794-1803

2012

Volltextzugriff (PDF)

Research on transformer remote faults diagnosis based on support vector machine

Mou, Shu Nan

2010

Volltextzugriff (PDF)

1 – 25 von 395

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(317)
Mit Volltextzugriff
(364)

Publikationsform

Sprache

Englisch
(325)
Chinesisch
(72)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(246)
Life Sciences & Biomedicine
(143)
Physical Sciences
(68)
Technology
(61)
Humans
(60)
Chemistry
(51)
Female
(43)
Animals
(41)
Male
(35)
Engineering
(34)
Science & Technology - Other Topics
(29)
Materials Science
(23)
Chemistry, Physical
(20)
Middle Aged
(20)
Pharmacology & Pharmacy
(20)
Chemistry, Multidisciplinary
(19)
Physics
(18)
Adult
(17)
Cell Biology
(15)
Engineering, Electrical & Electronic
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant

Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant

Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk

Three-dimensional prediction of nose morphology in Chinese young adults: a pilot study combining cone-beam computed tomography and 3dMD photogrammetry system

The expression and significance of efferocytosis and immune checkpoint related molecules in pancancer samples and the correlation of their expression with anticancer drug sensitivity

Lip morphology estimation models based on three-dimensional images in a modern adult population from China

Three-dimensional superimposition of digital models for individual identification

Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors

Efficacy and side effects of anti‐CD19 CAR T‐cell therapy in patients with relapsed/refractory gastrointestinal lymphoma

Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy

Trillium tschonoskii maxim extract attenuates abnormal Tau phosphorylation

Abstract 1499: Targeting Ras mutation with TCR therapy

Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia

Three-dimensional Structure Variation of PM 2.5 During Cold Front Advance in Eastern China

Luteolin attenuates the pathogenesis of Staphylococcus aureus by interfering with the agr system

Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL

Anti-CD19-CAR T-Cell from Patients Relapsed after Allo-HSCT with a Low Level of Donor Chimerism Restored to Complete Donor Chimerism: Successful Cases and Analysis

Humanized anti‐CD19 chimeric antigen receptor‐T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection

A Refractory B-ALL Patient Relapsed with Leukemia Cells Expressing CD19 and Anti-CD19 CAR Gene 14 Days after CR from Anti-CD19 CAR T-Cell Therapy

Humanized CD19 CAR-T Cell Combined with Multiple Combination Treatments in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Efficacy and safety of humanized CD19 CAR‑T as a salvage therapy for recurrent CNSL of B‑ALL following murine CD19 CAR‑T cell therapy

Targeting KRAS G12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors

Propagating Both Trust and Distrust with Target Differentiation for Combating Link-Based Web Spam

Genetic Structure and Diversity of Parental Cultivars Involved in China Mainland Sugarcane Breeding Programs as Inferred from DNA Microsatellites

Research on transformer remote faults diagnosis based on support vector machine

Suchergebnisse filtern